Regulatory & Legal

On World Hand Hygiene Day, experts warn of waning habits post-pandemic. Discover the simple, life-saving power of a 20-second scrub and its huge impact.

With profits up and a new CEO, TVA is pouring billions into new generation, betting on advanced nuclear power to meet soaring demand from data centers.

A breakthrough study validates a low-cost blood test that can detect multiple cancers and liver diseases, poised to transform preventative healthcare.

Operational failures at a key new mine pushed Peabody to a Q1 loss, overshadowing strong thermal coal profits fueled by geopolitical conflict.

Giyani Metals' high-purity manganese meets quality standards from US tech leader C4V, a crucial step in building a non-Chinese battery supply chain.

PowerBank's new 4.99 MW battery in Cramahe is online, boasting a lucrative 22-year contract and a groundbreaking 50% First Nations ownership stake.

A new drug, CS-1103, earns FDA Fast Track to combat fentanyl overdoses by binding and removing the opioid, a potential game-changer over naloxone.

New data reveals 61% of LGBTQ+ youth report poor mental health, yet a near-unanimous 97% find powerful reasons for hope amidst the struggle.

A new geological report confirms gold potential at Treasure Canyon, but for a company with no revenue, the path to riches is paved with high risk.

UK biotech Cytospire secures a major Series A to bring its novel pan-gamma delta T cell engagers, targeting tough solid tumors, into clinical trials.

As Saudi Arabia targets a 1.5GW data capacity by 2030, Datalec Precision Installations enters the market to build the infrastructure for this digital boom.

Figure Technology Solutions reports a 108% YoY surge in loan volume, signaling strong adoption of its blockchain-native financial products and tokenized assets.

A new report reveals a major gap between executive AI ambitions and daily agent reality, as teams face rising strain despite technological advances.

Marking its 10th anniversary, The War Zone rebrands to TWZ, expanding its digital footprint to meet growing demand for in-depth defense journalism.

Beyond its first blockbuster, CRISPR Therapeutics reveals a deep pipeline for autoimmune and liver diseases, backed by a strong Q1 balance sheet.

The trust advances major Toronto developments and improves its debt position, signaling a long-term strategy amid a challenging real estate market.

GECC appoints Jason Reese as CEO and waives fees to lift income, but falling asset values and a high-yield dividend raise questions for investors.

Claire Elyse Brosseau launches an emergency legal bid to access assisted dying for mental illness, challenging Canada's repeated legislative delays.

Fueled by strong investor demand, Panoro Minerals has boosted its financing to C$21M, accelerating development of its key Cotabambas copper-gold project.

New FDA-registered system from Clarapath offers labs a flexible, lower-cost entry into automation, targeting a critical bottleneck in pathology workflows.